GPC3 and neoplasm: A recent study constructed two types of CAR T-cells targeting different epitopes of GPC3 and found that both human YP7 CAR T-cells and 32A9 CAR T-cells possess GPC3-specific anti-tumor functions and inhibit tumor growth under in vitro and in vivo settings [87].